Droxidopa for refractory neurogenic orthostatic hypotension in amyloid light chain amyloidosis.Published in:American Journal of Pharmacotherapy & Pharmaceutical Sciences, 2023, p. 1, doi. 10.25259/AJPPS_2023_006By:Ha, Hien Le;Nguyen, Nguyen LPublication type:Article